Found: 46
Select item for more details and to access through your institution.
Prevalent expression of fibroblast growth factor (FGF) receptors and FGF2 in human tumor cell lines.
- Published in:
- International Journal of Cancer, 1999, v. 81, n. 3, p. 451, doi. 10.1002/(SICI)1097-0215(19990505)81:3<451::AID-IJC20>3.0.CO;2-H
- By:
- Publication type:
- Article
Targeting tumor cells via EGF receptors: Selective toxicity of an HBEGF-toxin fusion protein.
- Published in:
- International Journal of Cancer, 1998, v. 78, n. 1, p. 106, doi. 10.1002/(SICI)1097-0215(19980925)78:1<106::AID-IJC17>3.0.CO;2-9
- By:
- Publication type:
- Article
Long‐term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post‐treatment.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 320, doi. 10.1111/hae.14936
- By:
- Publication type:
- Article
Landmark endorsement of a global registry: The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP), publicly endorses World Federation of Hemophilia Gene Therapy Registry as global standard.
- Published in:
- Haemophilia, 2024, v. 30, n. 1, p. 232, doi. 10.1111/hae.14912
- By:
- Publication type:
- Article
A foundation to better care: Target product profile for haemophilia and Von Willebrand disease point‐of‐care diagnostics in low‐resource settings.
- Published in:
- Haemophilia, 2023, v. 29, n. 5, p. 1376, doi. 10.1111/hae.14853
- By:
- Publication type:
- Article
Reported prevalence of von Willebrand disease worldwide in relation to income classification.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 975, doi. 10.1111/hae.14810
- By:
- Publication type:
- Article
Towards achieving a haemophilia‐free mind.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 951, doi. 10.1111/hae.14807
- By:
- Publication type:
- Article
Von Willebrand Disease: Gaining a global perspective.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1104, doi. 10.1111/hae.14804
- By:
- Publication type:
- Article
Development of a target product profile (TTP) for haemophilia point‐of‐care (POC) diagnostic devices for low‐resource countries and remote settings.
- Published in:
- Haemophilia, 2023, v. 29, n. 2, p. 671, doi. 10.1111/hae.14739
- By:
- Publication type:
- Article
Theory of change and strategic priorities of the world federation of haemophilia.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 45, doi. 10.1111/hae.14673
- By:
- Publication type:
- Article
Sixth Åland Island Conference on von Willebrand disease.
- Published in:
- Haemophilia, 2022, v. 28, p. 3, doi. 10.1111/hae.14495
- By:
- Publication type:
- Article
Supporting patients with haemophilia in a world of crises: New role for the WFH and its partners.
- Published in:
- Haemophilia, 2022, v. 28, n. 4, p. 521, doi. 10.1111/hae.14610
- By:
- Publication type:
- Article
Persistence of haemostatic response following gene therapy with valoctocogene roxaparvovec in severe haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 947, doi. 10.1111/hae.14391
- By:
- Publication type:
- Article
Vaccination against COVID‐19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 515, doi. 10.1111/hae.14271
- By:
- Publication type:
- Article
Uncertainty in an era of transformative therapy for haemophilia: Addressing the unknowns.
- Published in:
- Haemophilia, 2021, v. 27, p. 103, doi. 10.1111/hae.14023
- By:
- Publication type:
- Article
Impact of humanitarian aid linked prophylaxis in Côte d'Ivoire (Ivory Coast).
- Published in:
- Haemophilia, 2021, v. 27, n. 1, p. 9, doi. 10.1111/hae.14246
- By:
- Publication type:
- Article
Reimbursing the value of gene therapy care in an era of uncertainty.
- Published in:
- Haemophilia, 2021, v. 27, n. 1, p. 12, doi. 10.1111/hae.14218
- By:
- Publication type:
- Article
Management of COVID‐19‐associated coagulopathy in persons with haemophilia.
- Published in:
- Haemophilia, 2021, v. 27, n. 1, p. 41, doi. 10.1111/hae.14191
- By:
- Publication type:
- Article
Gene therapy to cure haemophilia: Is robust scientific inquiry the missing factor?
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. 931, doi. 10.1111/hae.14131
- By:
- Publication type:
- Article
WFH Guidelines for the Management of Hemophilia, 3rd edition.
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. 1, doi. 10.1111/hae.14046
- By:
- Publication type:
- Article
The World Federation of Hemophilia Annual Global Survey 1999‐2018.
- Published in:
- Haemophilia, 2020, v. 26, n. 4, p. 591, doi. 10.1111/hae.14012
- By:
- Publication type:
- Article
World Federation of Hemophilia Gene Therapy Registry.
- Published in:
- Haemophilia, 2020, v. 26, n. 4, p. 563, doi. 10.1111/hae.14015
- By:
- Publication type:
- Article
The COVID‐19 pandemic: New global challenges for the haemophilia community.
- Published in:
- Haemophilia, 2020, v. 26, n. 3, p. 371, doi. 10.1111/hae.14001
- By:
- Publication type:
- Article
Towards a global multidisciplinary consensus framework on haemophilia gene therapy: Report of the 2nd World Federation of Haemophilia Gene Therapy Round Table.
- Published in:
- Haemophilia, 2020, v. 26, n. 3, p. 443, doi. 10.1111/hae.13971
- By:
- Publication type:
- Article
Safety and efficacy of emicizumab and other novel agents in newborns and infants.
- Published in:
- Haemophilia, 2019, v. 25, n. 5, p. e334, doi. 10.1111/hae.13822
- By:
- Publication type:
- Article
The 1st WFH Gene Therapy Round Table: Understanding the landscape and challenges of gene therapy for haemophilia around the world.
- Published in:
- Haemophilia, 2019, v. 25, n. 2, p. 189, doi. 10.1111/hae.13673
- By:
- Publication type:
- Article
The Enhancing Effects of the Light Chain on Heavy Chain Secretion in Split Delivery of Factor VIII Gene.
- Published in:
- Molecular Therapy, 2007, v. 15, n. 10, p. 1856, doi. 10.1038/sj.mt.6300268
- By:
- Publication type:
- Article
Evidence of Multiyear Factor IX Expression by AAV-Mediated Gene Transfer to Skeletal Muscle in an Individual with Severe Hemophilia B.
- Published in:
- Molecular Therapy, 2006, v. 14, n. 3, p. 452, doi. 10.1016/j.ymthe.2006.05.004
- By:
- Publication type:
- Article
Identification of factors that contribute to recombinant AAV2 particle aggregation and methods to prevent its occurrence during vector purification and formulation
- Published in:
- Molecular Therapy, 2005, v. 12, n. 1, p. 171, doi. 10.1016/j.ymthe.2005.02.021
- By:
- Publication type:
- Article
Adenovirus Encoding Human Platelet-Derived Growth Factor-B Delivered in Collagen Exhibits Safety, Biodistribution, and Immunogenicity Profiles Favorable for Clinical Use
- Published in:
- Molecular Therapy, 2004, v. 9, n. 5, p. 699, doi. 10.1016/j.ymthe.2004.02.018
- By:
- Publication type:
- Article
Delivery of FGF Genes to Wound Repair Cells Enhances Arteriogenesis and Myogenesis in Skeletal Muscle
- Published in:
- Molecular Therapy, 2002, v. 5, n. 5, p. 517, doi. 10.1006/mthe.2002.0579
- By:
- Publication type:
- Article
Role of platelet-derived growth factor in wound healing.
- Published in:
- Journal of Cellular Biochemistry, 1991, v. 45, n. 4, p. 319, doi. 10.1002/jcb.240450403
- By:
- Publication type:
- Article
A Single Chain Variant of Factor VIII Fc Fusion Protein Retains Normal In Vivo Efficacy but Exhibits Altered In Vitro Activity.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0113600
- By:
- Publication type:
- Article
Switching to recombinant factor IX Fc fusion protein prophylaxis results in fewer infusions, decreased factor IX consumption and lower bleeding rates.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 1, p. 113, doi. 10.1111/bjh.13109
- By:
- Publication type:
- Article
Actions of platelet-derived growth factor isoforms in mesangial cells.
- Published in:
- Journal of Cellular Physiology, 1994, v. 158, n. 1, p. 140, doi. 10.1002/jcp.1041580118
- By:
- Publication type:
- Article
Platelet-derived growth factor/sis in normal and neoplastic cell growth.
- Published in:
- Journal of Cellular Physiology, 1987, v. 133, p. 95, doi. 10.1002/jcp.1041330418
- By:
- Publication type:
- Article
Treatment of nonhealing diabetic foot ulcers with a platelet-derived growth factor gene-activated matrix (GAM501): Results of a Phase 1/2 trial.
- Published in:
- Wound Repair & Regeneration, 2009, v. 17, n. 6, p. 772, doi. 10.1111/j.1524-475X.2009.00541.x
- By:
- Publication type:
- Article
Matrix-enabled gene transfer for cutaneous wound repair.
- Published in:
- Wound Repair & Regeneration, 2000, v. 8, n. 6, p. 473, doi. 10.1046/j.1524-475X.2000.00473.x
- By:
- Publication type:
- Article
Role of hypoxia in growth factor responses: differential effects of basic fibroblast growth factor and platelet-derived growth factor in an ischemic wound model.
- Published in:
- Wound Repair & Regeneration, 1994, v. 2, n. 4, p. 277, doi. 10.1046/j.1524-475X.1994.20408.x
- By:
- Publication type:
- Article
Role of platelet-derived growth factor in osteoblast function and bone synthesis.
- Published in:
- Wound Repair & Regeneration, 1993, v. 1, n. 4, p. 203, doi. 10.1046/j.1524-475X.1993.10405.x
- By:
- Publication type:
- Article
Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A.
- Published in:
- Nature Medicine, 2013, v. 19, n. 10, p. 1318, doi. 10.1038/nm.3270
- By:
- Publication type:
- Article
CD8<sup>+</sup> T-cell responses to adeno-associated virus capsid in humans.
- Published in:
- Nature Medicine, 2007, v. 13, n. 4, p. 419, doi. 10.1038/nm1549
- By:
- Publication type:
- Article
CORRIGENDUM: Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response.
- Published in:
- 2006
- By:
- Publication type:
- Correction notice
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response.
- Published in:
- Nature Medicine, 2006, v. 12, n. 3, p. 342, doi. 10.1038/nm1358
- By:
- Publication type:
- Article
The Use of Purified Clotting Factor Concentrates in Hemophilia.
- Published in:
- JAMA: Journal of the American Medical Association, 1989, v. 261, n. 23, p. 3434, doi. 10.1001/jama.1989.03420230088032
- By:
- Publication type:
- Article
Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice.
- Published in:
- PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0148255
- By:
- Publication type:
- Article